Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipation Builds for CoDiagnostics Quarterly Earnings Report

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Biotechnology Stock Exchange
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Co-Diagnostics (NASDAQ: CODX) is gearing up to unveil its latest quarterly earnings report on March 14, 2024. Analysts are predicting an EPS of $-0.20 for this quarter.

In the previous quarter, Co-Diagnostics surprised everyone by surpassing EPS expectations by $0.09, causing a 10.24% decrease in the share price the next day.

As of March 12, the company’s stock was valued at $1.175, marking a 60.14% decline over the past year. Investors are eagerly awaiting not only a strong earnings performance but also optimistic guidance for future growth, as this can have a significant impact on stock prices.

CODX Stock Price Analysis: Slight Drop in Momentum on March 13, 2024

On March 13, 2024, CODX stock experienced a slight drop in its price momentum, trading in the middle of its 52-week range and below its 200-day simple moving average. The stock opened at $1.23, which was $0.05 higher than its previous close. Despite opening higher, the price of CODX shares decreased by $0.00 since the market last closed, resulting in a 0.36% drop. This slight decrease may have been influenced by various factors such as market conditions, investor sentiment, or company-specific news. Investors and analysts may be closely monitoring CODX stock performance to gauge its future trajectory. It will be interesting to see how the stock performs in the coming days and whether it can regain momentum to move towards its 200-day simple moving average. As always, it is important for investors to conduct thorough research and analysis before making any investment decisions. Stock prices can be volatile and unpredictable, so it is crucial to stay informed and make informed decisions based on reliable information.

CODX Stock Performance Analysis: Revenue Fluctuations and EPS Trends on March 13, 2024

On March 13, 2024, CODX stock experienced some interesting fluctuations in its financial performance. According to data from CNN Money, the company reported a total revenue of $34.22 million over the past year, which represents a significant decrease of 65.04% compared to the previous year. However, when looking at the quarterly revenue, CODX saw a substantial increase of 1142.18% since the last quarter, with total revenue reaching $2.46 million.

In terms of net income, CODX reported a loss of $14.24 million over the past year, indicating a decrease of 138.84% compared to the previous year. However, the company managed to reduce its losses in the last quarter, with a net loss of $5.98 million, representing an increase of 32.93% since the previous quarter.

Earnings per share (EPS) also showed mixed results for CODX stock. The company reported an EPS of -$0.45 over the past year, reflecting a decrease of 136.9% compared to the previous year. However, there was a positive trend in the last quarter, with an EPS of -$0.20, indicating an increase of 33.56% since the previous quarter.

Overall, the financial performance of CODX stock on March 13, 2024, showed a mix of positive and negative trends. Investors will be closely monitoring CODX stock to see if these trends continue in the future.

Tags: CODX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Charts for stock trading

Stifel Analyst Reaffirms Buy Rating for Equinix with 960 Price Target

Bellevue dues

Analysts Remain Bullish on Alcon with Buy Ratings and Price Target Increases

why did walmart get rid of price scanners

Truist Securities Analyst Reaffirms Positive Outlook on Keros Therapeutics with 100 Price Target

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com